C535-1013 Screening compound: 1-[3-(4-chlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine

C535-1013 Screening compound: 1-[3-(4-chlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine
C535-1013 Screening compound: 1-[3-(4-chlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine alternative view

Chemical Structure Depiction of ChemDiv screening compound C535-1013
1-[3-(4-chlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C535-1013

Molecular Formula

C25H30ClN5O (C25 H30 ClN5 O)

Compound Name

1-[3-(4-chlorophenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine

IUPAC name

1-[3-(4-chlorophenyl)-25-dimethylpyrazolo[15-a]pyrimidin-7-yl]-4-(piperidine-1-carbonyl)piperidine

SMILES

Cc1nn2c(N(CC3)CCC3C(N3CCCCC3)=O)cc(C)nc2c1-c(cc1)ccc1Cl

InChI

InChI=1S/C25H30ClN5O/c1-17-16-22(29-14-10-20(11-15-29)25(32)30-12-4-3-5-13-30)31-24(27-17)23(18(2)28-31)19-6-8-21(26)9-7-19/h6-9,16,20H,3-5,10-15H2,1-2H3

InChI Key

LRUXYYXEIJYUOX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14768684

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.695

Distribution Coefficient, logD

3.188

Water Solubility, LogSw

-5.04

Polar Surface Area

39.505

Acid Dissociation Constant (pKa)

23.23

Base Dissociation Constant (pKb)

8.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

C535-1013 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C535-1013 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C535-1013?
Check Price and Availability of C535-1013, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C535-1013 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C535-1013
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C535-1013
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C535-1013 available by request